Zidesamtinib (NVL-520)

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Zidesamtinib (NVL-520)
Treatment and conditionWhere it standsTrials
Zidesamtinib (NVL-520) for neoplasm metastasisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1